Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 29.71 CNY 0.2%
Market Cap: 47.8B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note

Relative Value

The Relative Value of one Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 52.34 CNY. Compared to the current market price of 29.71 CNY, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
52.34 CNY
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
79
Median 3Y
0.7
Median 5Y
0.7
Industry
2.6
Forward
0.6
vs History
55
vs Industry
34
Median 3Y
12.4
Median 5Y
13
Industry
23
Forward
14.5
vs History
12
vs Industry
30
Median 3Y
11.1
Median 5Y
11.1
Industry
17.8
vs History
3
vs Industry
27
Median 3Y
13.7
Median 5Y
13.7
Industry
25.4
vs History
88
vs Industry
49
Median 3Y
1.5
Median 5Y
1.6
Industry
2.2
vs History
31
vs Industry
82
Median 3Y
0.6
Median 5Y
0.6
Industry
2.8
Forward
0.6
vs History
20
vs Industry
57
Median 3Y
3.1
Median 5Y
3.5
Industry
5.4
vs History
36
vs Industry
35
Median 3Y
9.3
Median 5Y
10
Industry
13.7
Forward
8.6
vs History
36
vs Industry
38
Median 3Y
9.3
Median 5Y
10
Industry
17.2
Forward
9.9
vs History
6
vs Industry
33
Median 3Y
9.9
Median 5Y
9.6
Industry
16.5
vs History
6
vs Industry
27
Median 3Y
12.1
Median 5Y
12.1
Industry
19.3
vs History
84
vs Industry
57
Median 3Y
1.1
Median 5Y
1.2
Industry
2

Multiples Across Competitors

Competitors Multiples
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
48.2B CNY 0.6 12.7 10.9 10.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top